8-K current report · filed Aug 26, 2026

PHIBRO ANIMAL HEALTH CORP (PAHC) 8-K Current Report: August 26, 2026

Item 2.02Item EX-99.1PAHC overview

Short answer

PHIBRO ANIMAL HEALTH CORP (PAHC) filed an 8-K current report with the SEC on August 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Fiscal Q4 and FY2026 operating results announced for periods ended June 30, 2026.

PHIBRO ANIMAL HEALTH CORP 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Fiscal Q4 and FY2026 operating results announced for periods ended June 30, 2026
  • FY2027 financial guidance provided for the year ending June 30, 2027
  • Detailed results and guidance contained in furnished Exhibit 99.1 press release
  • Information furnished under Regulation FD, not filed under Exchange Act Section 18purposes

Item EX-99.1 · Exhibit EX-99.1

  • Fiscal 2026 sales $1,518.1M, up 17%, with Adjusted EBITDA $255.0M, up 39%, signaling strong post-MFA integration performance
  • Adjusted diluted EPS $3.22, up 48%, despite interest expense rising 28% to $44.4M after a $300.0M interest-rate swap expired
  • Fiscal 2027 guidance: sales $1.55B-$1.60B, Adjusted EBITDA $258M-$268M, adjusted EPS $3.41-$3.59
  • Chicago Heights plant closure planned for summer 2027, affecting approximately 100 employees and potentially creating one-time charges
  • Leverage remains material at 2.9x gross debt, with $737.9M total debt and $82.0M cash and short-term investments

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other PHIBRO ANIMAL HEALTH CORP 8-K filings

Get the next PAHC 8-K as it lands

Follow PAHC for push alerts, or ask the research agent what this filing means.